Intrathecal baclofen treatment in dystonic cerebral palsy: a randomized clinical trial: the IDYS trial

BACKGROUND: Dystonic cerebral palsy is primarily caused by damage to the basal ganglia and central cortex. The daily care of these patients can be difficult due to dystonic movements. Intrathecal baclofen treatment is a potential treatment option for dystonia and has become common practice. Despite...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonouvrié, Laura A, Becher, Jules G, Vles, Johannes SH, Boeschoten, Karin, Soudant, Dan, de Groot, Vincent, van Ouwerkerk, Willem JR, Strijers, Rob LM, Foncke, Elisabeth, Geytenbeek, Joke, van de Ven, Peter M, Teernstra, Onno, Vermeulen, R Jeroen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840690/
https://www.ncbi.nlm.nih.gov/pubmed/24165282
http://dx.doi.org/10.1186/1471-2431-13-175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840690/
https://www.ncbi.nlm.nih.gov/pubmed/24165282
http://dx.doi.org/10.1186/1471-2431-13-175

Ejemplares similares